Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone Taper vs Abrupt Cessation in Septic Shock
NCT01150409Phase 4Terminated
- Sponsor
- Cleveland Clinic
- Start
- May 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in septic shock comparing Hydrocortisone Taper with Placebo (Abrupt Cessation) (2 arms). Primary endpoint: Incidence of Hypotension Between Study Days 8 and 14 at Day 14. Started May 2008; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01150409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01150409.